Your browser doesn't support javascript.
loading
Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H.
Salama, April K S; Li, Shuli; Macrae, Erin R; Park, Jong-In; Mitchell, Edith P; Zwiebel, James A; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T.
Afiliação
  • Salama AKS; Duke University, Durham, NC.
  • Li S; ECOG-ACRIN Biostatistical Center, Boston, MA.
  • Macrae ER; Columbus Oncology and Hematology Associates, Columbus, OH.
  • Park JI; Medical College of Wisconsin, Milwaukee, WI.
  • Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.
  • Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Chen HX; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Gray RJ; ECOG-ACRIN Biostatistical Center, Boston, MA.
  • McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Hamilton SR; MD Anderson Cancer Center, Houston, TX.
  • Armstrong DK; Johns Hopkins University, Baltimore, MD.
  • Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.
  • Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.
  • Chen AP; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Flaherty KT; Massachusetts General Hospital, Boston, MA.
J Clin Oncol ; 38(33): 3895-3904, 2020 11 20.
Article em En | MEDLINE | ID: mdl-32758030
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Neoplasias Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Neoplasias Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article